Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 4450
Single User License Price INR 316796
Corporate User License Price USD 6250
Corporate User License Price INR 444938
Request a Quote

Report Title

Global Molecular Modelling Market Research Report - Forecast to 2023

Quote Request for License Type
License Type Price  
Single User License USD 4450
Enterprise Wide License USD 6250
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Global Molecular Modelling Market Research Report - Forecast to 2023


Quote Request for License Type
License Type Price  
Single User License USD 4450
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Global Molecular Modelling Market Research Report - Forecast to 2023

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Global Molecular Modelling Market Research Report - Forecast to 2023



Executive Summary

Introduction

Molecular modelling, as the name itself suggests, is concerned with molecules, their calculations, and predictions with respect to the research field. Molecular modelling can also be stated as an analysis of the ways to mimic the behaviour of molecules and molecular systems. Currently, molecular modelling is invariably associated with computer modelling, where computational biology techniques are involved. These molecular modelling techniques are widely used in the chemical and pharmaceutical industry. Molecular modelling plays a crucial role in drug discovery.

Molecular modelling has developed as a valuable and essential tool in various healthcare applications such as drug designing, drug development, and drug discovery processes. Molecular modelling describes the generation, manipulation, or representation of three-dimensional structures of molecules and associated physicochemical properties. The growth of the global molecular modelling market is attributed to the increasing investments in research and development by pharmaceutical and biotechnology companies, technological advancements in drug design, and increasing prevalence of various chronic diseases which increases the demand for drug development. However, the high cost of research and development is restraining the growth of the market.

Molecular modelling is a powerful technique in drug designing. The development of new drugs with possible therapeutic applications is one of the most difficult processes in the pharmaceutical industry. In drug designing and discovery, both computational and experimental techniques play important roles and represent complementary approaches. However, molecular modelling is safe and easy to use tool, which helps in investigating, interpreting, explaining, and identifying molecular properties using three-dimensional structures. During drug designing, molecular modelling tries to predict the structure of the intermolecular complex formed between two or more constituent molecules.

The global molecular modelling market is segmented based on the basis of product, application, end-user, and region.

Based on product, the market is further segmented into software and services.

Based on application, the market is segmented into drug development, drug discovery, and others.

Based on end-user, the market is segmented into pharmaceutical and biotechnological companies, research centres and academic institutions, and others.

The global molecular modelling market was valued at USD 377 million in 2017 and is expected to register a CAGR of 15.46% from 2018 to 2023.

Key Players

Simulations Plus, Inc., Chemical Computing Group, Certara, L.P, OpenEye Scientific Software, Dassault Systemes, Cambridge Crystallographic Data Centre, Cresset, Acellera Ltd., Schrodinger, LLC, Optibrium, BioSolve-IT, and others

Study objectives

To provide a detailed analysis of the market structure along with a forecast of various segments and sub-segments of the global molecular modelling market

To provide insights into factors influencing and affecting the market growth

To provide historical and forecast revenue of market segments and sub-segments with respect to countries

To provide strategic profiling of key players in the market and comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market

To provide economic factors that influence the global molecular modelling market

To provide a detailed analysis of the value chain and supply chain of the global molecular modelling market

Target Audience

Research and Development (R&D) Companies

Market Research and Consulting Service Providers

Academic Institutes and Universities

Potential Investors

Key Findings

The global molecular modelling market is expected to reach USD 893.1 million by 2023 at a CAGR of 15.46% from 2018 to 2023

Based on product, software accounted for the largest market share of 63.1% in the year 2017 and was valued at USD 237.79 million in the same year

Based on application, drug discovery accounted for the largest market share of 58.0% in 2017

The Americas holds the largest share of the global molecular modelling market which is expected to reach USD 470.6 million by 2023

Asia-Pacific is the fastest growing market, which is expected to register a CAGR of 14.65% from 2018 to 2023

Regional Analysis

Americas

o North America

o US

o Canada

o South America

Europe

o Germany

o France

o UK

o Italy

o Spain

o Rest of Europe

Asia-Pacific

o Japan

o China

o India

o Australia

o Republic of Korea

o Rest of Asia-Pacific

Middle East & Africa

o Middle East

o Africa

Table of Contents:

 

1 Report Prologue

2 Market Introduction

2.1 Definition

2.2 Scope of the Study

2.3 List of Assumptions

2.4 Market Structure

3 Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

3.5 Forecast Model

4 Market Dynamics

4.1 Introduction

4.2 Drivers

4.2.1 Increasing prevalence of various chronic diseases leading to drug development

4.2.2 Technological advancements in drug design

4.2.3 Increasing investments in research & development by pharmaceutical and biotechnology companies

4.3 Restraints

4.3.1 Higher cost of molecular modelling software

4.3.2 Lack of skilled healthcare IT professionals in low and middle-income economies

4.4 Opportunities

4.4.1 Introduction of molecular modelling software and services in developing economies

5 Market Factor Analysis

5.1 Porter's Five Forces Model

5.1.1 Threat of New Entrants

5.1.2 Bargaining Power of Suppliers

5.1.3 Bargaining Power of Buyers

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.2.1 Inputs

5.2.2 Software Development Processes

5.2.3 Output

5.2.4 Marketing and Distribution

5.2.5 Post-Selling Services

5.3 Investment Opportunity Analysis

5.4 Price Analysis

6 Global Molecular Modelling Market by Product

6.1 Introduction

6.2 Software

6.3 Services

7 Global Molecular Modelling Market by Application

7.1 Introduction

7.2 Drug Development

7.3 Drug Discovery

7.4 Others

8 Global Molecular Modelling Market by End User

8.1 Introduction

8.2 Pharmaceutical & Biotechnology Companies

8.3 Research & Academic Centers

8.4 Others

9 Global Molecular Modelling Market by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 U.K

9.3.1.4 Italy

9.3.1.5 Spain

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.4.6 Rest of Asia Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.2 Africa

10 Competitive Landscape

10.1 Introduction

10.2 Company Ranking

11 Company Profiles

11.1 Simulations Plus, Inc.

11.1.1 Company Overview

11.1.2 Financial Overview

11.1.3 Products Offering

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.1.6 Key Strategy

11.2 Cambridge Crystallographic Data Centre

11.2.1 Company Overview

11.2.2 Financial Overview

11.2.3 Products Offering

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.2.6 Key Strategy

11.3 Optibrium

11.3.1 Company Overview

11.3.2 Financial Overview

11.3.3 Products Offering

11.3.4 Key Developments

11.3.5 SWOT Analysis

11.3.6 Key Strategy

11.4 Cresset

11.4.1 Company Overview

11.4.2 Financial Overview

11.4.3 Products Offering

11.4.4 Key Developments

11.4.5 SWOT Analysis

11.4.6 Key Strategy

11.5 BioSolveIT GmbH

11.5.1 Company Overview

11.5.2 Financial Overview

11.5.3 Products Offering

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.5.6 Key Strategy

11.6 OpenEye Scientific Software

11.6.1 Company Overview

11.6.2 Financial Overview

11.6.3 Products Offering

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.6.6 Key Strategy

11.7 Chemical Computing Group

11.7.1 Company Overview

11.7.2 Financial Overview

11.7.3 Products Offering

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.7.6 Key Strategy

11.8 Acellera Ltd.

11.8.1 Company Overview

11.8.2 Financial Overview

11.8.3 Products Offering

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.8.6 Key Strategy

11.9 Dassault Systemes

11.9.1 Company Overview

11.9.2 Financial Overview

11.9.3 Products Offering

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.9.6 Key Strategy

11.1 Schrodinger, LLC

11.10.1 Company Overview

11.10.2 Financial Overview

11.10.3 Products Offering

11.10.4 Key Developments

11.10.5 SWOT Analysis

11.10.6 Key Strategy

11.11 Certara, L.P

11.11.1 Company Overview

11.11.2 Financial Overview

11.11.3 Products Offering

11.11.4 Key Developments

11.11.5 SWOT Analysis

11.11.6 Key Strategy

12 Appendix

12.1 Discussion Blue Print

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures:

 

FIGURE 1 GLOBAL MOLECULAR MODELLING MARKET: MARKET STRUCTURE

FIGURE 2 RESEARCH PROCESS OF MRFR

FIGURE 3 TOP DOWN & BOTTOM-UP APPROACH

FIGURE 4 PORTER'S FIVE FORCES ANALYSIS OF THE GLOBAL MOLECULAR MODELLING MARKET

FIGURE 5 VALUE CHAIN: MOLECULAR MODELLING MARKET

FIGURE 6 GLOBAL MOLECULAR MODELLING MARKET BY PRODUCT, 2017 & 2023 (USD MILLION)

FIGURE 7 GLOBAL MOLECULAR MODELLING MARKET BY APPLICATION, 2017 & 2023 (USD MILLION)

FIGURE 8 GLOBAL MOLECULAR MODELLING MARKET BY END USER, 2017 & 2023 (USD MILLION)

FIGURE 9 GLOBAL MOLECULAR MODELLING MARKET BY REGION, 2017 & 2023 (USD MILLION)

FIGURE 10 AMERICAS MOLECULAR MODELLING MARKET SHARE BY REGION, 2017 (%)

FIGURE 11 NORTH AMERICA MOLECULAR MODELLING MARKET SHARE BY COUNTRY, 2017 (%)

FIGURE 12 EUROPE MOLECULAR MODELLING MARKET SHARE BY REGION, 2017 (%)

FIGURE 13 WESTERN EUROPE MOLECULAR MODELLING MARKET SHARE BY COUNTRY, 2017 (%)

FIGURE 14 ASIA PACIFIC MOLECULAR MODELLING MARKET SHARE BY COUNTRY, 2017 (%)

FIGURE 15 MIDDLE EAST & AFRICA MOLECULAR MODELLING MARKET SHARE BY REGION, 2017 (%)

List of Tables:

 

TABLE 1 LIST OF ASSUMPTIONS

TABLE 2 GLOBAL MOLECULAR MODELLING MARKET BY PRODUCT, 2015 TO 2023 (USD MILLION)

TABLE 3 GLOBAL MOLECULAR MODELLING MARKET FOR SOFTWARE BY REGION, 2015 TO 2023 (USD MILLION)

TABLE 4 GLOBAL MOLECULAR MODELLING MARKET FOR SERVICES BY REGION, 2015 TO 2023 (USD MILLION)

TABLE 5 GLOBAL MOLECULAR MODELLING MARKET BY APPLICATION, 2015 TO 2023 (USD MILLION)

TABLE 6 GLOBAL MOLECULAR MODELLING MARKET FOR DRUG DEVELOPMENT BY REGION, 2015 TO 2023 (USD MILLION)

TABLE 7 GLOBAL MOLECULAR MODELLING MARKET FOR DRUG DISCOVERY BY REGION, 2015 TO 2023 (USD MILLION)

TABLE 8 GLOBAL MOLECULAR MODELLING MARKET FOR DRUG DISCOVERY BY TYPE, 2015 TO 2023 (USD MILLION)

TABLE 9 GLOBAL MOLECULAR MODELLING MARKET BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 10 GLOBAL MOLECULAR MODELLING MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY BY REGION, 2015 TO 2023 (USD MILLION)

TABLE 11 GLOBAL MOLECULAR MODELLING MARKET FOR RESEARCH & ACADEMIC CENTERS BY REGION, 2015 TO 2023 (USD MILLION)

TABLE 12 GLOBAL MOLECULAR MODELLING MARKET BY REGION, 2015 TO 2023 (USD MILLION)

TABLE 13 AMERICAS MOLECULAR MODELLING MARKET BY REGION, 2015 TO 2023 (USD MILLION)

TABLE 14 AMERICAS MOLECULAR MODELLING MARKET BY PRODUCT, 2015 TO 2023 (USD MILLION)

TABLE 15 AMERICAS MOLECULAR MODELLING MARKET BY APPLICATION, 2015 TO 2023 (USD MILLION)

TABLE 16 AMERICAS MOLECULAR MODELLING MARKET FOR DRUG DISCOVERY BY TYPE, 2015 TO 2023 (USD MILLION)

TABLE 17 AMERICAS MOLECULAR MODELLING MARKET BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 18 NORTH AMERICA MOLECULAR MODELLING MARKET BY COUNTRY, 2015 TO 2023 (USD MILLION)

TABLE 19 NORTH AMERICA MOLECULAR MODELLING MARKET BY PRODUCT, 2015 TO 2023 (USD MILLION)

TABLE 20 NORTH AMERICA MOLECULAR MODELLING MARKET BY APPLICATION, 2015 TO 2023 (USD MILLION)

TABLE 21 NORTH AMERICA MOLECULAR MODELLING MARKET FOR DRUG DISCOVERY BY TYPE, 2015 TO 2023 (USD MILLION)

TABLE 22 NORTH AMERICA MOLECULAR MODELLING MARKET BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 23 US MOLECULAR MODELLING MARKET BY PRODUCT, 2015 TO 2023 (USD MILLION)

TABLE 24 US MOLECULAR MODELLING MARKET BY APPLICATION, 2015 TO 2023 (USD MILLION)

TABLE 25 US MOLECULAR MODELLING MARKET FOR DRUG DISCOVERY BY TYPE, 2015 TO 2023 (USD MILLION)

TABLE 26 US MOLECULAR MODELLING MARKET BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 27 CANADA MOLECULAR MODELLING MARKET BY PRODUCT, 2015 TO 2023 (USD MILLION)

TABLE 28 CANADA MOLECULAR MODELLING MARKET BY APPLICATION, 2015 TO 2023 (USD MILLION)

TABLE 29 CANADA MOLECULAR MODELLING MARKET FOR DRUG DISCOVERY BY TYPE, 2015 TO 2023 (USD MILLION)

TABLE 30 CANADA MOLECULAR MODELLING MARKET BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 31 SOUTH AMERICA MOLECULAR MODELLING MARKET BY PRODUCT, 2015 TO 2023 (USD MILLION)

TABLE 32 SOUTH AMERICA MOLECULAR MODELLING MARKET BY APPLICATION, 2015 TO 2023 (USD MILLION)

TABLE 33 SOUTH AMERICA MOLECULAR MODELLING MARKET FOR DRUG DISCOVERY BY TYPE, 2015 TO 2023 (USD MILLION)

TABLE 34 SOUTH AMERICA MOLECULAR MODELLING MARKET BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 35 EUROPE MOLECULAR MODELLING MARKET BY REGION, 2015 TO 2023 (USD MILLION)

TABLE 36 EUROPE MOLECULAR MODELLING MARKET BY PRODUCT, 2015 TO 2023 (USD MILLION)

TABLE 37 EUROPE MOLECULAR MODELLING MARKET BY APPLICATION, 2015 TO 2023 (USD MILLION)

TABLE 38 EUROPE MOLECULAR MODELLING MARKET FOR DRUG DISCOVERY BY TYPE, 2015 TO 2023 (USD MILLION)

TABLE 39 EUROPE MOLECULAR MODELLING MARKET BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 40 WESTERN EUROPE MOLECULAR MODELLING MARKET BY COUNTRY, 2015 TO 2023 (USD MILLION)

TABLE 41 WESTERN EUROPE MOLECULAR MODELLING MARKET BY PRODUCT, 2015 TO 2023 (USD MILLION)

TABLE 42 WESTERN EUROPE MOLECULAR MODELLING MARKET BY APPLICATION, 2015 TO 2023 (USD MILLION)

TABLE 43 WESTERN EUROPE MOLECULAR MODELLING MARKET FOR DRUG DISCOVERY BY TYPE, 2015 TO 2023 (USD MILLION)

TABLE 44 WESTERN EUROPE MOLECULAR MODELLING MARKET BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 45 GERMANY MOLECULAR MODELLING MARKET BY PRODUCT, 2015 TO 2023 (USD MILLION)

TABLE 46 GERMANY MOLECULAR MODELLING MARKET BY APPLICATION, 2015 TO 2023 (USD MILLION)

TABLE 47 GERMANY MOLECULAR MODELLING MARKET FOR DRUG DISCOVERY BY TYPE, 2015 TO 2023 (USD MILLION)

TABLE 48 GERMANY MOLECULAR MODELLING MARKET BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 49 FRANCE MOLECULAR MODELLING MARKET BY PRODUCT, 2015 TO 2023 (USD MILLION)

TABLE 50 FRANCE MOLECULAR MODELLING MARKET BY APPLICATION, 2015 TO 2023 (USD MILLION)

TABLE 51 FRANCE MOLECULAR MODELLING MARKET FOR DRUG DISCOVERY BY TYPE, 2015 TO 2023 (USD MILLION)

TABLE 52 FRANCE MOLECULAR MODELLING MARKET BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 53 U.K MOLECULAR MODELLING MARKET BY PRODUCT, 2015 TO 2023 (USD MILLION)

TABLE 54 U.K MOLECULAR MODELLING MARKET BY APPLICATION, 2015 TO 2023 (USD MILLION)

TABLE 55 U.K MOLECULAR MODELLING MARKET FOR DRUG DISCOVERY BY TYPE, 2015 TO 2023 (USD MILLION)

TABLE 56 U.K MOLECULAR MODELLING MARKET BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 57 ITALY MOLECULAR MODELLING MARKET BY PRODUCT, 2015 TO 2023 (USD MILLION)

TABLE 58 ITALY MOLECULAR MODELLING MARKET BY APPLICATION, 2015 TO 2023 (USD MILLION)

TABLE 59 ITALY MOLECULAR MODELLING MARKET FOR DRUG DISCOVERY BY TYPE, 2015 TO 2023 (USD MILLION)

TABLE 60 ITALY MOLECULAR MODELLING MARKET BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 61 SPAIN MOLECULAR MODELLING MARKET BY PRODUCT, 2015 TO 2023 (USD MILLION)

TABLE 62 SPAIN MOLECULAR MODELLING MARKET BY APPLICATION, 2015 TO 2023 (USD MILLION)

TABLE 63 SPAIN MOLECULAR MODELLING MARKET FOR DRUG DISCOVERY BY TYPE, 2015 TO 2023 (USD MILLION)

TABLE 64 SPAIN MOLECULAR MODELLING MARKET BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 65 REST OF WESTERN EUROPE MOLECULAR MODELLING MARKET BY PRODUCT, 2015 TO 2023 (USD MILLION)

TABLE 66 REST OF WESTERN EUROPE MOLECULAR MODELLING MARKET BY APPLICATION, 2015 TO 2023 (USD MILLION)

TABLE 67 REST OF WESTERN EUROPE MOLECULAR MODELLING MARKET FOR DRUG DISCOVERY BY TYPE, 2015 TO 2023 (USD MILLION)

TABLE 68 REST OF WESTERN EUROPE MOLECULAR MODELLING MARKET BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 69 EASTERN EUROPE MOLECULAR MODELLING MARKET BY PRODUCT, 2015 TO 2023 (USD MILLION)

TABLE 70 EASTERN EUROPE MOLECULAR MODELLING MARKET BY APPLICATION, 2015 TO 2023 (USD MILLION)

TABLE 71 EASTERN EUROPE MOLECULAR MODELLING MARKET FOR DRUG DISCOVERY BY TYPE, 2015 TO 2023 (USD MILLION)

TABLE 72 EASTERN EUROPE MOLECULAR MODELLING MARKET BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 73 ASIA PACIFIC MOLECULAR MODELLING MARKET BY COUNTRY, 2015 TO 2023 (USD MILLION)

TABLE 74 ASIA PACIFIC MOLECULAR MODELLING MARKET BY PRODUCT, 2015 TO 2023 (USD MILLION)

TABLE 75 ASIA PACIFIC MOLECULAR MODELLING MARKET BY APPLICATION, 2015 TO 2023 (USD MILLION)

TABLE 76 ASIA PACIFIC MOLECULAR MODELLING MARKET FOR DRUG DISCOVERY BY TYPE, 2015 TO 2023 (USD MILLION)

TABLE 77 ASIA PACIFIC MOLECULAR MODELLING MARKET BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 78 JAPAN MOLECULAR MODELLING MARKET BY PRODUCT, 2015 TO 2023 (USD MILLION)

TABLE 79 JAPAN MOLECULAR MODELLING MARKET BY APPLICATION, 2015 TO 2023 (USD MILLION)

TABLE 80 JAPAN MOLECULAR MODELLING MARKET FOR DRUG DISCOVERY BY TYPE, 2015 TO 2023 (USD MILLION)

TABLE 81 JAPAN MOLECULAR MODELLING MARKET BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 82 CHINA MOLECULAR MODELLING MARKET BY PRODUCT, 2015 TO 2023 (USD MILLION)

TABLE 83 CHINA MOLECULAR MODELLING MARKET BY APPLICATION, 2015 TO 2023 (USD MILLION)

TABLE 84 CHINA MOLECULAR MODELLING MARKET FOR DRUG DISCOVERY BY TYPE, 2015 TO 2023 (USD MILLION)

TABLE 85 CHINA MOLECULAR MODELLING MARKET BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 86 INDIA MOLECULAR MODELLING MARKET BY PRODUCT, 2015 TO 2023 (USD MILLION)

TABLE 87 INDIA MOLECULAR MODELLING MARKET BY APPLICATION, 2015 TO 2023 (USD MILLION)

TABLE 88 INDIA MOLECULAR MODELLING MARKET FOR DRUG DISCOVERY BY TYPE, 2015 TO 2023 (USD MILLION)

TABLE 89 INDIA MOLECULAR MODELLING MARKET BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 90 AUSTRALIA MOLECULAR MODELLING MARKET BY PRODUCT, 2015 TO 2023 (USD MILLION)

TABLE 91 AUSTRALIA MOLECULAR MODELLING MARKET BY APPLICATION, 2015 TO 2023 (USD MILLION)

TABLE 92 AUSTRALIA MOLECULAR MODELLING MARKET FOR DRUG DISCOVERY BY TYPE, 2015 TO 2023 (USD MILLION)

TABLE 93 AUSTRALIA MOLECULAR MODELLING MARKET BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 94 SOUTH KOREA MOLECULAR MODELLING MARKET BY PRODUCT, 2015 TO 2023 (USD MILLION)

TABLE 95 SOUTH KOREA MOLECULAR MODELLING MARKET BY APPLICATION, 2015 TO 2023 (USD MILLION)

TABLE 96 SOUTH KOREA MOLECULAR MODELLING MARKET FOR DRUG DISCOVERY BY TYPE, 2015 TO 2023 (USD MILLION)

TABLE 97 SOUTH KOREA MOLECULAR MODELLING MARKET BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 98 REST OF ASIA PACIFIC MOLECULAR MODELLING MARKET BY PRODUCT, 2015 TO 2023 (USD MILLION)

TABLE 99 REST OF ASIA PACIFIC MOLECULAR MODELLING MARKET BY APPLICATION, 2015 TO 2023 (USD MILLION)

TABLE 100 REST OF ASIA PACIFIC MOLECULAR MODELLING MARKET FOR DRUG DISCOVERY BY TYPE, 2015 TO 2023 (USD MILLION)

TABLE 101 REST OF ASIA PACIFIC MOLECULAR MODELLING MARKET BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 102 MIDDLE EAST & AFRICA MOLECULAR MODELLING MARKET BY REGION, 2015 TO 2023 (USD MILLION)

TABLE 103 MIDDLE EAST & AFRICA MOLECULAR MODELLING MARKET BY PRODUCT, 2015 TO 2023 (USD MILLION)

TABLE 104 MIDDLE EAST & AFRICA MOLECULAR MODELLING MARKET BY APPLICATION, 2015 TO 2023 (USD MILLION)

TABLE 105 MIDDLE EAST & AFRICA MOLECULAR MODELLING MARKET FOR DRUG DISCOVERY BY TYPE, 2015 TO 2023 (USD MILLION)

TABLE 106 MIDDLE EAST & AFRICA MOLECULAR MODELLING MARKET BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 107 MIDDLE EAST MOLECULAR MODELLING MARKET BY PRODUCT, 2015 TO 2023 (USD MILLION)

TABLE 108 MIDDLE EAST MOLECULAR MODELLING MARKET BY APPLICATION, 2015 TO 2023 (USD MILLION)

TABLE 109 MIDDLE EAST MOLECULAR MODELLING MARKET FOR DRUG DISCOVERY BY TYPE, 2015 TO 2023 (USD MILLION)

TABLE 110 MIDDLE EAST MOLECULAR MODELLING MARKET BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 111 AFRICA MOLECULAR MODELLING MARKET BY PRODUCT, 2015 TO 2023 (USD MILLION)

TABLE 112 AFRICA MOLECULAR MODELLING MARKET BY APPLICATION, 2015 TO 2023 (USD MILLION)

TABLE 113 AFRICA MOLECULAR MODELLING MARKET FOR DRUG DISCOVERY BY TYPE, 2015 TO 2023 (USD MILLION)

TABLE 114 AFRICA MOLECULAR MODELLING MARKET BY END USER, 2015 TO 2023 (USD MILLION)

Simulations Plus Inc.

Cambridge Crystallographic Data Centre

Optibrium

Cresset

BioSolveIT GmbH

OpenEye Scientific Software

Chemical Computing Group

Acellera Ltd.

Dassault Systemes

Schrodinger LLC

Certara L.P


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person